GLP1R and obesity disorder: Flavonifractor is associated with several diseases, such as obesity [50], atrial fibrillation [51], coronary artery disease [52], and medications (antidiabetic drugs, such as Metformin and Glucagon-like peptide 1 Receptor agonist [53]).